Estimation of serum immunoglobulin E level in asthma and its correlation with Epstein Barr Virus (EBV) infection
Article Sidebar
Main Article Content
Abstract
This study carried out to show the association between Epstein-Barr
Virus (EBV) infection and asthma. a cohort 65 serum samples were
collected from asthma patients within age group of 15-62 years ( 37
females and 28 males) and 20 healthy controls. The levels of IgE and
EBV IgM antibodies were measured by ELISA assay. The results
showed that IgE levels increased with severity of asthma (327.95 IU/ml)
and the high level of IgE in asthma patients with age group (45-55 years)
was 306 IU/ml. Sero detection of EBV showed that EBV infection
increased with severity of asthma and was highest in females with severe
asthma. serum IgE levels were high in asthmatic as compared to healthy
controls and the highest levels of it was in severity of asthma. On other
hand, there was weak significant correlation between levels of IgE and
EBV infections in asthma patients
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Tikrit Journal of Pure Science is licensed under the Creative Commons Attribution 4.0 International License, which allows users to copy, create extracts, abstracts, and new works from the article, alter and revise the article, and make commercial use of the article (including reuse and/or resale of the article by commercial entities), provided the user gives appropriate credit (with a link to the formal publication through the relevant DOI), provides a link to the license, indicates if changes were made, and the licensor is not represented as endorsing the use made of the work. The authors hold the copyright for their published work on the Tikrit J. Pure Sci. website, while Tikrit J. Pure Sci. is responsible for appreciate citation of their work, which is released under CC-BY-4.0, enabling the unrestricted use, distribution, and reproduction of an article in any medium, provided that the original work is properly cited.
References
[1] Boulet, L.P. (2009). Influence of comorbid conditions on asthma. Eur. Respir. J., 3(4): 897-906.
[2] American Thoracic Society (ATS). (2000). Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am. J. Respir. Crit. Care. Med., 162:2341-51.
[3] Holgate, S.T; Holloway, J; Wilson , S; Howarth, P.H; Haitchi, H.M; Babu, S; & Davies, D. E. (2006). Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities. J. Allergy Clin. Immunol., 117:496-506.
[4] Husain, A. N and Kumar, V. (2007).The lung. In: Kumar, V; Abbas, A. K and Fausto,N; editors. Robbins and Cotran pathologic basis of disease. 7th ed. Philadelphia W B: Saunders; pp: 711-72
[5] Mathias, C.B; Freyschmidt, E.J; & Oettgen, H.C. (2009). Immunoglobulin E antibodies enhance pulmonary inflammation induced by inhalation of a chemical hapten. Clin. Exp. Allergy, 39:304–306.
[6] Kindt, T.J; Goldsby, R.A; & Osborne, B. (2007). Kuby Immunology 6th ed. New York: WH Freeman and Company, pp. 380–385.
[7] Weiss, K.B; Gergen, P.J; & Hodgson, T.A. (1992). An economic evaluation of asthma in the United States. N. Engl. J. Med., 326:862–866.
[8] Pattemore, P.K; Johnston, S.L; & Bardin, P.G. (1992). Viruses as precipitants of asthma symptoms. I. Epidemiology. Clin. Exp. Allergy, 22:325–336.
[9] Stark, J.M. and Graziano, F.M. (1995). Lower Airway Response to Viruses. In Asthma and Rhinitis. W.W. Busse, and S.T. Holgate, editors. Blackwell Scientific Publications, Boston, MA. 1229–1243.
[10] Arbes, S. J; Guo, X; Orelien, J. et al. (2004). Interaction between sex and age in the prevalence of current asthma. J. Allergy Clin. Immuno., 113: 302.
[11] Global Strategy for Asthma Management and Prevention. (2006). Global Initiative for Asthma (GINA). www.ginasthma.org.
[12] Frick, O. L, German, D.F; & Mills, J. (1979). Development of allergy in children: association with
virus infection. J. Allergy Clin. Immunol., 64:228-241.
[13]Griffin, D. E, Cooper, S. J; Hirsch, R.C; Johnson, R.J; Lindo de Soriano, I; Roedenbeck, S. et al., (1985). Changes in plasma IgE levels during complicated and uncomplicated measles virus infections. J. Allergy clin. immunol., 76:206-213
[14] Wingate, P. J; McAulay, K.A; Anthony, I.C; & Crawford. D.H. (2009). Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. J. Med. Virol., 81(5):870-877.
[15] Marshall, N.A; Culligan, D.J; Johnston, P.W; Millar, C; Barker, R.N; Vickers, M. A. (2007). CD4 (+) T-cell responses to Epstein-Barr virus (EBV) latent membrane protein 1 in infectious mononucleosis and EBV-associated non-Hodgkin lymphoma: Th1 in active disease but Tr1 in remission. Br. J. Haematol., 139(1):81-89.
[16] Raftery, M.J; Wieland, D; Gronewald, S; Kraus, A.A; Giese, T; & Schonrich, G. (2004). Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. J. of Immunol., 173(5): 3383-3391
[17] Nilsson, C; Larsson Sigfrinius, A.K; Montgomery, S. M; Sverremark - Ekstrom, E; Linde, A; Lilja, G; & Blomberg, M. T. (2009). Epstein-Barr virus and cytomegalovirus are differentially associated with numbers of cytokine-producing cells and early atopy. Clin. Exp. Allergy, 39(4):509-517
[18] Nilsson, C; Linde, A; Montgomery, S. M; Gustafsson, L; Nasman, P; Blomberg, M.T; & Lilja, G. (2005). Does early EBV infection protect against IgE sensitization?. J. Allergy Clin. Immunol., 116(2): 438-444.
[19] Welliver, R.C; Wong, D.T; Sun, M; Middleton, Jr. E; Vaughan, R.S; & Ogra, P. L. (1981). The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med., 305:841-846
[20] Welliver, R; Wong, D; Middleton, E; Sun, M; McCarthy, N; Ogra, P. (1982). Role of parainfluenza virus-specific IgE in pathogenesis of croup and wheezing subsequent to infection. J. Pediatr., 101: 889–896.
[21] Bahna, S. L; Horwitz, C.A; Fiala, M; & Heiner, D.C. (1978). IgE response in heterophil-positive infectious mononucleosis. J. Allergy. Clin. Immunol., 62:167
[22] Strannegard, I. L. and Strannegard, O. (1981). Epstein-Barr virus antibodies in children with atopic diseases. Int. Arch. Allergy Appl. lmmunol., 64: 314.
[23] Rystedt, I; Strannegard, I.L; & Strannegard, O. (1984). Increased serum levels of antibodies Co Epstein-Barr virus in adults with history of atopic dermatitis, lnt. Arch. Allergy Appl. Immunol., 75:179,
[24] Veiga, R. V; Sergio, S. C; Vitor , C. D; Álvaro, C .C; Phillip, J. C; Laura, C. R; Maurício, L. B; &Neuza, M. A. (2011). Chronic virus infections supress atopy but not asthma in a set of children from a large latin american city: a cross-section study. BMC Pulmonary Medicine, 11:24
[25] Lundberg, P; Welander, P; Han, X; & Cantin, E. (2003). Herpes simplex virus type 1 DNA is immunostimulatory in vitro and in vivo. J. Virol., 77(20):11158-11169.